Levulan Kerastick Kit
Product Images NDC 67308-101

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Levulan Kerastick (NDC 67308-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levulan 01

Two photographs of hands holding a thin, white, rectangular strip with markings, presumably part of the LEVULAN KERASTICK kit. The images show the strip from different angles, focusing on its use or design.*

FDA Label Image

Levulan 02

Illustration showing the use of LEVULAN KERASTICK, a prescription kit containing aminolevulinic acid hydrochloride. The images depict hands demonstrating how to handle and prepare the applicator device, including removing a protective cap and readying the stick for application.*

FDA Label Image

Levulan 03

Illustration showing a person's forearm in four sequential images demonstrating the application of protective coverings: a bare arm, an arm wrapped in transparent plastic wrap, an arm covered with a netted sleeve, and finally an arm outfitted with a white protective glove and sleeve.*

FDA Label Image

Levulan 04

Chemical structure of aminolevulinic acid hydrochloride, the active ingredient in LEVULAN KERASTICK. The diagram shows the molecular arrangement including functional groups and ionic form with chloride.*

FDA Label Image

Levulan 05

A flowchart diagram illustrating a clinical trial study design and outcomes for LEVULAN KERASTICK compared to a vehicle control. The chart tracks patient numbers enrolled, randomized, treated, and their clearance status across weeks 0, 8, and 12.*

FDA Label Image

Levulan 06

A line graph titled 'Percent of Subjects With 100% of Treated Lesions Cleared (Complete Responders) by Month (N=110 Subjects)'. The x-axis represents months from 3 to 12, and the y-axis shows the percentage of subjects with 100% lesion clearance ranging from 0 to 100%. The graph plots a declining trend starting at 65.5% at month 3, gradually decreasing to 30.9% by month 12.*

FDA Label Image

Levulan 07

A line graph titled "Percent of Lesions Cleared at Month 3 and Remaining Clear Through Month 12 (N=748 Lesions)" showing the percentage of treated lesions cleared on the y-axis and months 3 to 12 on the x-axis. The graph depicts a decreasing trend in the percentage of lesions cleared from 83.4% at month 3 to 63.6% at month 12.*

FDA Label Image

Levulan 08

A flowchart diagram depicting patient treatment outcomes over 12 weeks. It shows groups enrolled and treated with either LEVULAN/light or Vehicle/light, with subsequent results of 'Clear' or 'Not Clear' at weeks 0, 8, and 12, including numbers of patients retreated in each category.*

FDA Label Image

Levulan 09

FDA Label Image

Levulan 10

FDA Label Image

Levulan 11

Label for LEVULAN KERASTICK 20% aminolevulinic acid hydrochloride topical solution kit. The single-use applicator contains 1.5 mL. The label includes a barcode, lot number and expiration date fields, manufacturing information for Sun Pharmaceutical Industries, Inc., Billerica, MA, and the Sun Pharma logo.*

FDA Label Image

Levulan 12

Packaging label for LEVULAN KERASTICK kit containing aminolevulinic acid hydrochloride for topical solution, 20%. The label features the product name, active ingredient, strength, and dosage form. It includes the Sun Pharmaceutical Industries, Inc. logo and branding in orange and white colors, with usage and manufacturing information on various panels of the carton design.*

FDA Label Image

Levulan 13

Flat die-cut packaging label for LEVULAN KERASTICK kit by Sun Pharmaceutical Industries, Inc. Text on the label includes information about 6 single-use applicators of 1.5 mL each and instructions to follow step-by-step directions for preparing the application, with references to crush points indicated on each Kerastick.*

FDA Label Image

Levulan 14

Label for LEVULAN KERASTICK containing aminolevulinic acid hydrochloride 20% topical solution, single-use applicator 1.5 mL. The label indicates it is a sample not for sale, manufactured by Sun Pharmaceutical Industries, Inc. The label includes NDC 67308-101-01 and fields for lot number and expiration date, with directions to crush on the sides marked 'A' and 'B'.*

FDA Label Image

Levulan 15

Packaging label for LEVULAN KERASTICK kit containing aminolevulinic acid hydrochloride 20% topical solution. The kit includes two single-use applicators, each 1.6 mL. Labeler is Sun Pharmaceutical Industries, Inc. The package prominently states "Sample - Not For Sale" and includes instructions and warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.